Article Details

Novartis bets $1.6B on a biotech's anti-inflammatory drugs

Retrieved on: 2019-04-01 00:07:30

Tags for this article:

Click the tags to see associated articles and topics

Novartis bets $1.6B on a biotech's anti-inflammatory drugs. View article details on hiswai:

Excerpt

<div>... by the CANTOS trial, among others," wrote <b>Atlas Venture</b> partner Bruce Booth in a Monday blog post. <b>Atlas Venture</b> is one of the co-founders of IFM.</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up